Apr 26, 2023 / 05:30PM GMT
Moderator
Our next presentation this morning is going to be Michael McFadden with Alpha Cognition.
Michael McFadden - Alpha Cognition Inc. - CEO & Director
I'll give an overview of Alpha Cognition and some exciting developments for the company with our lead compound ALPHA-1062. For those of you who don't know, Alpha Cognition is a biopharmaceutical company. We're focused primarily on Alzheimer's. And then we have secondary and third indications we're pursuing with our pipeline.
A bit about Alpha Cognition, we believe we formulated this drug as a best-in-class treatment for the Alzheimer's market. The Alzheimer's market is a really large market, a $5.5 billion market, 11 named prescriptions every year, but it's characterized by high drug dissatisfaction, high dissatisfaction from physicians, and high discontinuation rates for patients.
Ours is an oral therapy designed to solve some of the problems that exist in the market today. And we have a pipeline that will expand utilization of our compound. We've completed most -- all of our clinical studies,
Alpha Cognition Inc at Precious Metals Summit Planet Microcap Showcase Transcript
Apr 26, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers